Search results
A'ja Wilson's sage advice for young Black girls, athletes on 'big sponsorship,' mental health
ClutchPoints· 6 hours agoLas Vegas Aces star A'ja Wilson was recently spotlighted on Times Magazine's list of the 100 most...
Sage (SAGE) Down 20% on Parkinson's Study Missing Primary Goal
Zacks· 7 days agoData from a mid-stage study show that Sage's (SAGE) experimental oral drug failed to show a statistically significant difference in treating patients with Parkinson's disease compared with a placebo.
GH’s Cameron Mathison Shares Life-Changing Lessons From His Decades-Long Acting Career
SOAPHUB via Yahoo News· 12 hours agoGH's Cameron Mathison has sage advice that applies to any aspect of your life. The post GH’s Cameron...
Clean Away: An Earth Day Essay And Thank You From Artist Sage Bava
Forbes· 3 days agoThe relationship between music and nature is a long and storied one. From Neil Young’s brilliant...
Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success
Zacks via Yahoo Finance· 6 days agoAdditionally, feedback from...depressive episodes associated with bipolar I or II disorder in adults...
Scotiabank Trims Sage Therapeutics (NASDAQ:SAGE) Target Price to $19.00
ETF DAILY NEWS· 4 days agoSage Therapeutics (NASDAQ:SAGE – Free Report) had its target price decreased by Scotiabank from $34.00 to $19.00 in a research note issued to investors ...
Biogen sees ‘encouraging’ trends for postpartum depression drug
BioPharma Dive via Yahoo Finance· 16 hours agoThe company didn’t, however, reveal the number of prescriptions filled for Zurzuvae, making demand...
TikTok CEO expects to defeat US ban: 'We aren't going anywhere'
FOX Business· 6 hours agoBiden's signing sets a Jan. 19 deadline for a sale - one day before his term is set to expire - but...
Sage Therapeutics (NASDAQ:SAGE) Rating Reiterated by Wedbush
ETF DAILY NEWS· 7 days agoWedbush reiterated their neutral rating on shares of Sage Therapeutics (NASDAQ:SAGE – Free Report) in a report issued on Wednesday morning, Benzinga reports ...
Sage Therapeutics (NASDAQ:SAGE) Price Target Cut to $17.00 by Analysts at Oppenheimer
ETF DAILY NEWS· 6 days agoSage Therapeutics (NASDAQ:SAGE – Free Report) had its price objective cut by Oppenheimer from $25.00 to $17.00 in a research note released on Thursday morning ...